Brain Tumor Diagnostics and Therapeutics Market, Global Outlook and Forecast 2022-2028

Brain Tumor Diagnostics and Therapeutics Market, Global Outlook and Forecast 2022-2028

Report Code: KNJ1318675 | No. of Pages: 68 | Category: Medical Devices
Publisher: Market Monitor Global | Date of Publish: May-2022
This report contains market size and forecasts of Brain Tumor Diagnostics and Therapeutics in Global, including the following market information:
Global Brain Tumor Diagnostics and Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Brain Tumor Diagnostics and Therapeutics market was valued at  million in 2021 and is projected to reach US$  million by 2028, at a CAGR of  % during the forecast period 2022-2028.
The U.S. Market is Estimated at $  Million in 2021, While China is Forecast to Reach $  Million by 2028.
Surgery Segment to Reach $  Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Brain Tumor Diagnostics and Therapeutics include Pfizer, Novartis, Roche, Merck, Curtana Pharmaceuticals, GE Healthcare, Hitachi Medical, Philips Healthcare and Novocure, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Brain Tumor Diagnostics and Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Brain Tumor Diagnostics and Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Brain Tumor Diagnostics and Therapeutics Market Segment Percentages, by Type, 2021 (%)
    Surgery
    Radiation Therapy
    Targeted Therapy
    Chemotherapy
    Others
Global Brain Tumor Diagnostics and Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Brain Tumor Diagnostics and Therapeutics Market Segment Percentages, by Application, 2021 (%)
    Hospitals and Cancer Center
    Oncology Treatment Centers
    Others
Global Brain Tumor Diagnostics and Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Brain Tumor Diagnostics and Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Brain Tumor Diagnostics and Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Brain Tumor Diagnostics and Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Pfizer
    Novartis
    Roche
    Merck
    Curtana Pharmaceuticals
    GE Healthcare
    Hitachi Medical
    Philips Healthcare
    Novocure
    AbbVie
    Daiichi Sankyo
    Genetech
    Carthera
    EMulate Therapeutics
1 Introduction to Research & Analysis Reports
    1.1 Brain Tumor Diagnostics and Therapeutics Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Brain Tumor Diagnostics and Therapeutics Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Brain Tumor Diagnostics and Therapeutics Overall Market Size
    2.1 Global Brain Tumor Diagnostics and Therapeutics Market Size: 2021 VS 2028
    2.2 Global Brain Tumor Diagnostics and Therapeutics Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Brain Tumor Diagnostics and Therapeutics Players in Global Market
    3.2 Top Global Brain Tumor Diagnostics and Therapeutics Companies Ranked by Revenue
    3.3 Global Brain Tumor Diagnostics and Therapeutics Revenue by Companies
    3.4 Top 3 and Top 5 Brain Tumor Diagnostics and Therapeutics Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Brain Tumor Diagnostics and Therapeutics Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Brain Tumor Diagnostics and Therapeutics Players in Global Market
        3.6.1 List of Global Tier 1 Brain Tumor Diagnostics and Therapeutics Companies
        3.6.2 List of Global Tier 2 and Tier 3 Brain Tumor Diagnostics and Therapeutics Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Brain Tumor Diagnostics and Therapeutics Market Size Markets, 2021 & 2028
        4.1.2 Surgery
        4.1.3 Radiation Therapy
        4.1.4 Targeted Therapy
        4.1.5 Chemotherapy
        4.1.6 Others
    4.2 By Type - Global Brain Tumor Diagnostics and Therapeutics Revenue & Forecasts
        4.2.1 By Type - Global Brain Tumor Diagnostics and Therapeutics Revenue, 2017-2022
        4.2.2 By Type - Global Brain Tumor Diagnostics and Therapeutics Revenue, 2023-2028
        4.2.3 By Type - Global Brain Tumor Diagnostics and Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Brain Tumor Diagnostics and Therapeutics Market Size, 2021 & 2028
        5.1.2 Hospitals and Cancer Center
        5.1.3 Oncology Treatment Centers
        5.1.4 Others
    5.2 By Application - Global Brain Tumor Diagnostics and Therapeutics Revenue & Forecasts
        5.2.1 By Application - Global Brain Tumor Diagnostics and Therapeutics Revenue, 2017-2022
        5.2.2 By Application - Global Brain Tumor Diagnostics and Therapeutics Revenue, 2023-2028
        5.2.3 By Application - Global Brain Tumor Diagnostics and Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Brain Tumor Diagnostics and Therapeutics Market Size, 2021 & 2028
    6.2 By Region - Global Brain Tumor Diagnostics and Therapeutics Revenue & Forecasts
        6.2.1 By Region - Global Brain Tumor Diagnostics and Therapeutics Revenue, 2017-2022
        6.2.2 By Region - Global Brain Tumor Diagnostics and Therapeutics Revenue, 2023-2028
        6.2.3 By Region - Global Brain Tumor Diagnostics and Therapeutics Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Brain Tumor Diagnostics and Therapeutics Revenue, 2017-2028
        6.3.2 US Brain Tumor Diagnostics and Therapeutics Market Size, 2017-2028
        6.3.3 Canada Brain Tumor Diagnostics and Therapeutics Market Size, 2017-2028
        6.3.4 Mexico Brain Tumor Diagnostics and Therapeutics Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Brain Tumor Diagnostics and Therapeutics Revenue, 2017-2028
        6.4.2 Germany Brain Tumor Diagnostics and Therapeutics Market Size, 2017-2028
        6.4.3 France Brain Tumor Diagnostics and Therapeutics Market Size, 2017-2028
        6.4.4 U.K. Brain Tumor Diagnostics and Therapeutics Market Size, 2017-2028
        6.4.5 Italy Brain Tumor Diagnostics and Therapeutics Market Size, 2017-2028
        6.4.6 Russia Brain Tumor Diagnostics and Therapeutics Market Size, 2017-2028
        6.4.7 Nordic Countries Brain Tumor Diagnostics and Therapeutics Market Size, 2017-2028
        6.4.8 Benelux Brain Tumor Diagnostics and Therapeutics Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Brain Tumor Diagnostics and Therapeutics Revenue, 2017-2028
        6.5.2 China Brain Tumor Diagnostics and Therapeutics Market Size, 2017-2028
        6.5.3 Japan Brain Tumor Diagnostics and Therapeutics Market Size, 2017-2028
        6.5.4 South Korea Brain Tumor Diagnostics and Therapeutics Market Size, 2017-2028
        6.5.5 Southeast Asia Brain Tumor Diagnostics and Therapeutics Market Size, 2017-2028
        6.5.6 India Brain Tumor Diagnostics and Therapeutics Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Brain Tumor Diagnostics and Therapeutics Revenue, 2017-2028
        6.6.2 Brazil Brain Tumor Diagnostics and Therapeutics Market Size, 2017-2028
        6.6.3 Argentina Brain Tumor Diagnostics and Therapeutics Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Brain Tumor Diagnostics and Therapeutics Revenue, 2017-2028
        6.7.2 Turkey Brain Tumor Diagnostics and Therapeutics Market Size, 2017-2028
        6.7.3 Israel Brain Tumor Diagnostics and Therapeutics Market Size, 2017-2028
        6.7.4 Saudi Arabia Brain Tumor Diagnostics and Therapeutics Market Size, 2017-2028
        6.7.5 UAE Brain Tumor Diagnostics and Therapeutics Market Size, 2017-2028
7 Players Profiles
    7.1 Pfizer
        7.1.1 Pfizer Corporate Summary
        7.1.2 Pfizer Business Overview
        7.1.3 Pfizer Brain Tumor Diagnostics and Therapeutics Major Product Offerings
        7.1.4 Pfizer Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
        7.1.5 Pfizer Key News
    7.2 Novartis
        7.2.1 Novartis Corporate Summary
        7.2.2 Novartis Business Overview
        7.2.3 Novartis Brain Tumor Diagnostics and Therapeutics Major Product Offerings
        7.2.4 Novartis Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
        7.2.5 Novartis Key News
    7.3 Roche
        7.3.1 Roche Corporate Summary
        7.3.2 Roche Business Overview
        7.3.3 Roche Brain Tumor Diagnostics and Therapeutics Major Product Offerings
        7.3.4 Roche Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
        7.3.5 Roche Key News
    7.4 Merck
        7.4.1 Merck Corporate Summary
        7.4.2 Merck Business Overview
        7.4.3 Merck Brain Tumor Diagnostics and Therapeutics Major Product Offerings
        7.4.4 Merck Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
        7.4.5 Merck Key News
    7.5 Curtana Pharmaceuticals
        7.5.1 Curtana Pharmaceuticals Corporate Summary
        7.5.2 Curtana Pharmaceuticals Business Overview
        7.5.3 Curtana Pharmaceuticals Brain Tumor Diagnostics and Therapeutics Major Product Offerings
        7.5.4 Curtana Pharmaceuticals Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
        7.5.5 Curtana Pharmaceuticals Key News
    7.6 GE Healthcare
        7.6.1 GE Healthcare Corporate Summary
        7.6.2 GE Healthcare Business Overview
        7.6.3 GE Healthcare Brain Tumor Diagnostics and Therapeutics Major Product Offerings
        7.6.4 GE Healthcare Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
        7.6.5 GE Healthcare Key News
    7.7 Hitachi Medical
        7.7.1 Hitachi Medical Corporate Summary
        7.7.2 Hitachi Medical Business Overview
        7.7.3 Hitachi Medical Brain Tumor Diagnostics and Therapeutics Major Product Offerings
        7.7.4 Hitachi Medical Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
        7.7.5 Hitachi Medical Key News
    7.8 Philips Healthcare
        7.8.1 Philips Healthcare Corporate Summary
        7.8.2 Philips Healthcare Business Overview
        7.8.3 Philips Healthcare Brain Tumor Diagnostics and Therapeutics Major Product Offerings
        7.8.4 Philips Healthcare Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
        7.8.5 Philips Healthcare Key News
    7.9 Novocure
        7.9.1 Novocure Corporate Summary
        7.9.2 Novocure Business Overview
        7.9.3 Novocure Brain Tumor Diagnostics and Therapeutics Major Product Offerings
        7.9.4 Novocure Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
        7.9.5 Novocure Key News
    7.10 AbbVie
        7.10.1 AbbVie Corporate Summary
        7.10.2 AbbVie Business Overview
        7.10.3 AbbVie Brain Tumor Diagnostics and Therapeutics Major Product Offerings
        7.10.4 AbbVie Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
        7.10.5 AbbVie Key News
    7.11 Daiichi Sankyo
        7.11.1 Daiichi Sankyo Corporate Summary
        7.11.2 Daiichi Sankyo Business Overview
        7.11.3 Daiichi Sankyo Brain Tumor Diagnostics and Therapeutics Major Product Offerings
        7.11.4 Daiichi Sankyo Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
        7.11.5 Daiichi Sankyo Key News
    7.12 Genetech
        7.12.1 Genetech Corporate Summary
        7.12.2 Genetech Business Overview
        7.12.3 Genetech Brain Tumor Diagnostics and Therapeutics Major Product Offerings
        7.12.4 Genetech Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
        7.12.5 Genetech Key News
    7.13 Carthera
        7.13.1 Carthera Corporate Summary
        7.13.2 Carthera Business Overview
        7.13.3 Carthera Brain Tumor Diagnostics and Therapeutics Major Product Offerings
        7.13.4 Carthera Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
        7.13.5 Carthera Key News
    7.14 EMulate Therapeutics
        7.14.1 EMulate Therapeutics Corporate Summary
        7.14.2 EMulate Therapeutics Business Overview
        7.14.3 EMulate Therapeutics Brain Tumor Diagnostics and Therapeutics Major Product Offerings
        7.14.4 EMulate Therapeutics Brain Tumor Diagnostics and Therapeutics Revenue in Global Market (2017-2022)
        7.14.5 EMulate Therapeutics Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com